Effects of different doses of erythropoietin in patients with myelodysplastic syndromes: A propensity score-matched analysis.

Enrico BalleariRosa Angela FilibertiChiara SalvettiBernardino AllioneEmanuele AngelucciMarco BruzzoneTullio CalzamigliaMarina CavaliereMaurizio CavalleriDaniela CilloniMarino ClavioElena CrisàAnna Da ColPaolo DaniseFederica PiloDario FerreroCarlo FinelliDaniela GioiaRoberto Massimo LemoliElisa MasieraEmanuela MessaMaurizio MiglinoPellegrino MustoEsther Natalie OlivaAntonella PoloniFlavia SalviAlessandro SannaMarco ScudelettiRodolfo TassaraValeria Santini

Published in: Cancer medicine (2019)

SD are substantially equally effective to HD to improve anemia and influencing survival in MDS patients stratified according to similar propensity to be exposed to rhEPO treatment.

Keyphrases

end stage renal disease
chronic kidney disease
ejection fraction
newly diagnosed
peritoneal dialysis
patient reported outcomes
combination therapy
patient reported
smoking cessation